- Report
- July 2024
- 120 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- February 2025
- 100 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- October 2024
- 195 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- July 2024
- 144 Pages
Global
From €2867EUR$2,999USD£2,400GBP
- Report
- April 2025
- 297 Pages
Global
From €5354EUR$5,600USD£4,482GBP
- Report
- April 2025
- 304 Pages
Global
From €5354EUR$5,600USD£4,482GBP
- Report
- April 2025
- 268 Pages
Global
From €5354EUR$5,600USD£4,482GBP
- Report
- April 2025
- 276 Pages
Global
From €5211EUR$5,450USD£4,362GBP
- Report
- April 2025
- 486 Pages
Global
From €5211EUR$5,450USD£4,362GBP
- Report
- April 2025
- 169 Pages
Global
From €5354EUR$5,600USD£4,482GBP
- Report
- April 2025
- 182 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 183 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 197 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 196 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 194 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 181 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 194 Pages
Global
From €4733EUR$4,950USD£3,962GBP
- Report
- April 2025
- 194 Pages
Global
From €5211EUR$5,450USD£4,362GBP
- Report
- April 2025
- 93 Pages
Global
From €5354EUR$5,600USD£4,482GBP
- Report
- April 2025
- 96 Pages
Global
From €5354EUR$5,600USD£4,482GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more